ArticleAnnals of medicine and surgery (2012)2022

Subcutaneous golimumab to treat a biological naïve chronically active ulcerative colitis child. A case report.

Marouf M Alhalabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.